EP0547140A4 - Immunosuppressant composition - Google Patents

Immunosuppressant composition

Info

Publication number
EP0547140A4
EP0547140A4 EP19910916526 EP91916526A EP0547140A4 EP 0547140 A4 EP0547140 A4 EP 0547140A4 EP 19910916526 EP19910916526 EP 19910916526 EP 91916526 A EP91916526 A EP 91916526A EP 0547140 A4 EP0547140 A4 EP 0547140A4
Authority
EP
European Patent Office
Prior art keywords
immunosuppressant composition
immunosuppressant
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19910916526
Other versions
EP0547140A1 (en
Inventor
William B. Cowden
David O. Willenborg
Christopher R. Parish
Kerry M. Bowen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Australian National University
Teva Pharmaceuticals Australia Pty Ltd
Original Assignee
Australian National University
Peptide Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Australian National University, Peptide Technology Ltd filed Critical Australian National University
Publication of EP0547140A1 publication Critical patent/EP0547140A1/en
Publication of EP0547140A4 publication Critical patent/EP0547140A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
EP19910916526 1990-09-06 1991-09-05 Immunosuppressant composition Withdrawn EP0547140A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPK216590 1990-09-06
AU2165/90 1990-09-06

Publications (2)

Publication Number Publication Date
EP0547140A1 EP0547140A1 (en) 1993-06-23
EP0547140A4 true EP0547140A4 (en) 1993-10-13

Family

ID=3774939

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910916526 Withdrawn EP0547140A4 (en) 1990-09-06 1991-09-05 Immunosuppressant composition

Country Status (2)

Country Link
EP (1) EP0547140A4 (en)
WO (1) WO1992004055A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1714977T3 (en) 2001-10-19 2009-07-06 Isotechnika Inc Synthesis of cyclosporin analogs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989011274A1 (en) * 1988-05-16 1989-11-30 The United States Of America, As Represented By Th Chemotherapeutic composition for aids
AU618838B2 (en) * 1988-08-10 1992-01-09 Praxis Pharmaceuticals, Inc. Use of castanospermine as an anti-inflammatory and immunosuppressant agent
US5011829A (en) * 1989-06-02 1991-04-30 G. D. Searle & Co. Pharmaceutical composition and method of inhibiting virus

Also Published As

Publication number Publication date
WO1992004055A1 (en) 1992-03-19
EP0547140A1 (en) 1993-06-23

Similar Documents

Publication Publication Date Title
GB9026065D0 (en) Composition
GB9005440D0 (en) Composition
GB9005856D0 (en) Compositions
GB9021546D0 (en) Novel composition
EP0445659A3 (en) Hair-set composition
GB9006537D0 (en) Composition
GB9015822D0 (en) Compositions
EP0449616A3 (en) Polyurethaneurea composition
GB9015892D0 (en) Compositions
EP0452632A3 (en) Dichloro-pentafluoropropanes-containing compositions
EP0517916A4 (en) Immunosuppressant
EP0547140A4 (en) Immunosuppressant composition
GB9004832D0 (en) Compositions
GB2248066B (en) Furnish composition
GB9011069D0 (en) Combined garment-rail/decking-beam
EP0449796A3 (en) Polyurethane-terpolymer blends
ZA914494B (en) Athelmintic composition
HU208481B (en) Mouth-hygienicd compositions
GB9119138D0 (en) Composition
GB9025681D0 (en) Composition
GB9024605D0 (en) Composition
IE901322L (en) Composition
GB9024604D0 (en) Composition
GB9021196D0 (en) Composition
GB9021140D0 (en) Composition

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19930312

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB IT

A4 Supplementary search report drawn up and despatched

Effective date: 19930824

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): DE FR GB IT

17Q First examination report despatched

Effective date: 19960729

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19970916